Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:59 AM
Ignite Modification Date:
2025-12-25 @ 12:59 AM
NCT ID:
NCT05025293
Eligibility Criteria:
Inclusion Criteria:
* Low energy hip fracture
* Surgery within 72 hours
* \>50 years old norwegian
* Women age 50-60 must be postmenopausal or not pregnant
* Acceptable kidney function (estimated GFR \>=35) and calcium levels
* Fit to complete the follow-up judged by the recruiting physician
* Signed informed consent by the patient or the next of kin
Exclusion Criteria:
* Metal in the opposite hip
* Anti-osteoporosis treatment with bisphosphonates, denosumab, teriparatide, abaloparatide or romosozumab within the last 10 years
* Glucocorticoid therapy
* Too sick to receive treatment with zoledronate judged by the recruiting or treating physician
* Any other contraindication listed on the SmPC of the IMP(s) including pregnancy
* Participating in another trial that might affect the current study
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
50 Years
Study:
NCT05025293
Study Brief:
Protocol Section:
NCT05025293